Global Non-opioid Analgesic Patch Market Survey and Trend Research 2018

September 2018 | 73 pages | ID: G82618473FEEN
99Strategy

Abstracts

Summary


This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Acorda Therapeutics, Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Non-opioid Analgesic Patch Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NON-OPIOID ANALGESIC PATCH MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 GlaxoSmithKline Plc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Pfizer, Inc. (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Teikoku Seiyaku Co., Ltd. (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Mylan N.V. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Acorda Therapeutics, Inc (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Acorda Therapeutics, Inc (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Endo International plc (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Allergan (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Teh Seng Pharmaceutical Mfg (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 IBSA Institut Biochimque SA (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Non-opioid Analgesic Patch Market 2012-2017, by Type, in USD Million
Table Global Non-opioid Analgesic Patch Market 2012-2017, by Type, in Volume
Table Global Non-opioid Analgesic Patch Market Forecast 2018-2023, by Type, in USD Million
Table Global Non-opioid Analgesic Patch Market Forecast 2018-2023, by Type, in Volume
Table GlaxoSmithKline Plc Overview List
Table Non-opioid Analgesic Patch Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Non-opioid Analgesic Patch Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teikoku Seiyaku Co., Ltd. Overview List
Table Non-opioid Analgesic Patch Business Operation of Teikoku Seiyaku Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan N.V. Overview List
Table Non-opioid Analgesic Patch Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acorda Therapeutics, Inc Overview List
Table Non-opioid Analgesic Patch Business Operation of Acorda Therapeutics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acorda Therapeutics, Inc Overview List
Table Non-opioid Analgesic Patch Business Operation of Acorda Therapeutics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo International plc Overview List
Table Non-opioid Analgesic Patch Business Operation of Endo International plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Non-opioid Analgesic Patch Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teh Seng Pharmaceutical Mfg Overview List
Table Non-opioid Analgesic Patch Business Operation of Teh Seng Pharmaceutical Mfg (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table IBSA Institut Biochimque SA Overview List
Table Non-opioid Analgesic Patch Business Operation of IBSA Institut Biochimque SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Non-opioid Analgesic Patch Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Non-opioid Analgesic Patch Sales Revenue Share, by Companies, in USD Million
Table Global Non-opioid Analgesic Patch Sales Volume 2012-2017, by Companies, in Volume
Table Global Non-opioid Analgesic Patch Sales Revenue Share, by Companies in 2017, in Volume
Table Non-opioid Analgesic Patch Demand 2012-2017, by Application, in USD Million
Table Non-opioid Analgesic Patch Demand 2012-2017, by Application, in Volume
Table Non-opioid Analgesic Patch Demand Forecast 2018-2023, by Application, in USD Million
Table Non-opioid Analgesic Patch Demand Forecast 2018-2023, by Application, in Volume
Table Global Non-opioid Analgesic Patch Market 2012-2017, by Region, in USD Million
Table Global Non-opioid Analgesic Patch Market 2012-2017, by Region, in Volume
Table Non-opioid Analgesic Patch Market Forecast 2018-2023, by Region, in USD Million
Table Non-opioid Analgesic Patch Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Non-opioid Analgesic Patch Industry Chain Structure
Figure Global Non-opioid Analgesic Patch Market Growth 2012-2017, by Type, in USD Million
Figure Global Non-opioid Analgesic Patch Market Growth 2012-2017, by Type, in Volume
Figure Global Non-opioid Analgesic Patch Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Non-opioid Analgesic Patch Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region